DXB Square Logo
Dimerix
(ASX:DXB)


 

  Our Initial Entry
Price

Portfolio Initiation

5 Day VWAP
After Initiation

Current Price

Our Current Returns

ASX:DXB
$0.200
$0.400
Aug 16 2021
$0.348
$0.125
    -38%

ASX:DXB
Our Current Returns
-38%




Overview

What does DXB do?

DXB is an early stage biotech research company that is developing an anti-inflammatory drug to treat respiratory and kidney diseases, with potential applications to treat COVID.

What is the macro theme behind DXB?

Due to the pandemic, biotech and life sciences have been at the forefront of global decision making for investors, governments and ordinary consumers.

What was once an industry that was considered slow and niche is now rapidly evolving with innovation and technology.